DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Piramal Pharma Limited — Board Meeting Intimation

NSE 17 hrs ago·20 Jul 2026, 7:07 am

Piramal Pharma

Piramal Pharma Limited has announced that its Board of Directors will convene a meeting on July 29, 2026. The primary agenda for this session is to review and approve the company's unaudited financial results for the quarter that ended in June 2026.

This announcement is a routine corporate update that signals the upcoming release of quarterly performance data. For investors, this is a key moment to monitor as the results will provide fresh insights into the company's operational health and financial trajectory for the period.

Investors should keep an eye on the specific details regarding revenue growth, profit margins, and any commentary on future business outlooks that will be disclosed during the board meeting.